Brief: Krensavage Asset Management Says Co Remains Opposed to Sun's Predatory Bid for Taro
30/01/2024 12:11
Jan 30 (Reuters) - Krensavage Asset Management:
* KRENSAVAGE ASSET MANAGEMENT REMAINS OPPOSED TO SUN'S
PREDATORY
BID FOR TARO
Source text for Eikon: ID:nPn2g0nHma
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma